Ovizio Imaging Systems, a Belgian company founded in December 2009, develops and commercializes a quantitative microscopic imaging platform technology based on patented Differential Digital Holographic Microscopy (DDHM), enabling automation of current manual processes. With Cell Therapy and Vaccines production as areas of focus, Ovizio Imaging Systems is establishing its footprint in the Bioprocessing market, maintaining Innovation and offering Cutting-Edge technologies that is central to the company’s strategic approach.
Ovizio’s microscopes offer a label-free tool for real-time 3D imaging of living cells.
Its iLine F microscope, core product of the portfolio, allows an in-line, automated and in closed loop monitoring of cells in suspension growing in bioreactor (stirred tanks, wave bags,..) delivering quantitative and qualitative information such as cell viability, cell counting, cell morphology at a single cell level; with a high reproducibility.
The OsOne software is at the center of Ovizio's microscopes and combine data acquisition and analysis with Machine Learning.